NEWS

Congress Passes Bill to Restart $4 Billion SBIR and STTR Programs After Five Month Shutdown

US Capitol building where Congress passed the SBIR STTR reauthorization bill restoring small business R&D funding

The U.S. House of Representatives voted 345 to 41 on March 17, 2026, to pass the Small Business Innovation and Economic Security Act (S. 3971), reauthorizing the SBIR and STTR federal innovation programs through September 30, 2031. The bill, which the Senate passed unanimously on March 3, now heads to the president’s desk for signature. The vote ends a five-month funding freeze that left nearly $6 billion stranded and roughly 4,000 small businesses per year locked out of new awards.

Key Takeaways
  • The House passed the SBIR/STTR reauthorization bill 345-41 on March 17, 2026, unlocking nearly $6 billion in frozen funding for small business R&D.
  • The programs, which distribute approximately $4 billion per year to about 4,000 companies, had been shut down since September 30, 2025.
  • A new “Strategic Breakthrough Awards” provision allows grants of up to $30 million per company for startups ready to scale federally funded technology.

What the SBIR and STTR Reauthorization Includes

SBIR (Small Business Innovation Research) and STTR (Small Business Technology Transfer) are federal grant programs that fund early-stage R&D at small businesses, with awards typically ranging from $50,000 in Phase I to $2 million in Phase II. The programs are administered by 11 federal agencies, including the National Science Foundation, National Institutes of Health, and Department of Defense. Both programs lapsed on September 30, 2025, after the Senate failed to pass a stopgap extension before the deadline.

The new law extends authorization through fiscal year 2031 and introduces several structural changes. The most significant is the creation of Strategic Breakthrough Awards, a new funding tier that allows qualifying small businesses to receive up to $30 million with a performance period capped at 48 months, according to the bill’s provisions. Eligibility requires a prior Phase II award and 100% matching funds from private capital or qualifying government sources.

The legislation also introduces proposal submission caps per fiscal year, standardized model contracts across all three phases, and enhanced training requirements for contracting officers handling Phase III awards.

National Security Provisions Tighten Foreign Oversight

The reauthorization significantly expands national security screening for applicants. New due diligence requirements now include checks against the Section 889 Prohibition List, the Military End User List, and Chinese military company designations, according to FedScoop’s reporting on the bill. STTR applicants face heightened scrutiny that extends to their partner nonprofit research institutions and individuals involved in the partnership.

Only agencies with $100 million or more in annual SBIR obligations are eligible to issue Strategic Breakthrough Awards. The allocation for those awards is capped at 0.50% of each agency’s extramural R&D budget annually, and Department of Defense applicants face additional technology maturity and acquisition pathway requirements.

Five Months of Frozen Funding Affected Thousands of Startups

The five-month lapse halted new solicitations and awards at agencies across the federal government, leaving startups that depend on SBIR and STTR grants in a holding pattern. Todd McCracken, president and CEO of the National Small Business Association, said in a statement following the vote that the passage was a win for the 4,000-plus companies per year that rely on the programs to bring innovations to market.

The bill received bipartisan support in both chambers. Senators Joni Ernst (R-IA) and Ed Markey (D-MA) led negotiations in the Senate, while Representatives Roger Williams (R-TX) and Nydia Velazquez (D-NY) shepherded the bill through the House. Velazquez called the programs responsible for “groundbreaking technologies that have revolutionized medicine, telecommunications, and military capabilities.” For founders exploring alternative funding routes, the reopening of SBIR and STTR adds another non-dilutive option back to the table.

What This Means for Founders Building in Deep Tech

The reauthorization restores the largest federal funding pipeline dedicated specifically to small business R&D. Companies in biotech, defense technology, clean energy, robotics, and AI infrastructure are among the most common recipients. The new Strategic Breakthrough Awards provision, with grants up to $30 million, is designed to help startups bridge the gap between research and commercialization, a stage where many vertical AI startups and deep-tech founders have historically struggled to secure capital.

The bill now awaits the president’s signature. Once signed, federal agencies can begin reopening solicitations, though the timeline for resuming disbursements will vary. Companies that had applications in progress when the programs lapsed should check with their respective agencies for updated submission windows.

Frequently Asked Questions

What Are the SBIR and STTR Programs?

SBIR (Small Business Innovation Research) and STTR (Small Business Technology Transfer) are federal programs that award grants of up to $2 million to small businesses conducting research and development. Established in 1982 and 1992 respectively, they fund roughly 4,000 companies per year across agencies including the NSF, NIH, and Department of Defense.

How Much Funding Was Frozen During the SBIR STTR Lapse?

Nearly $6 billion in SBIR and STTR funding was frozen after the programs lapsed on September 30, 2025. The reauthorization bill, which now awaits the president’s signature, would unlock that money and extend both programs through September 30, 2031.

When Will SBIR and STTR Funding Resume?

The bill passed both the Senate and House as of March 17, 2026, and now heads to the president’s desk for signature. Once signed into law, agencies can resume issuing new solicitations and awards, though the exact timeline for resuming disbursements will vary by agency.

Read More From the NEWS desk